Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer

~14 mi. (Torino, Italy, +153 more cities)

AO Azienda Ospedaliera Ordine Mauriziano Di Torino

Bladder Urothelial Carcinoma, +2 more conditions

BCG solution, +1 more drug

immunotherapy

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

~14 mi. (Torino, Italy, +170 more cities)

Novartis Investigative Site

ER Negative, +4 more biomarkers

Breast Carcinoma

alpelisib, +1 more drug

chemotherapy, +1 more type

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

~14 mi. (Torino, Italy, +64 more cities)

Ospedale S. Anna - A.O.U. Città della Salute e della Scienza

ER Positive, +1 more biomarker

Breast Carcinoma

anastrozole, +2 more drugs

hormone therapy

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

~14 mi. (Torino, Italy, +108 more cities)

Dermatologia Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino

BRAF V600E

Non-Small Cell Lung Carcinoma

binimetinib, +1 more drug

targeted therapy

MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

~14 mi. (Torino, Italy, +34 more cities)

A.O.U. Città della Salute e della Scienza di Torino Ospedale Molinette

MS4A1 Expression

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +2 more conditions

ibrutinib, +1 more drug

immunotherapy, +1 more type

Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma

~14 mi. (Torino, Italy, +12 more cities)

AOU Citta della Salute e della Scienza- Presidio Ospedaliero Infantile Regina Margherita

BRAF V600E, +1 more biomarker

Cutaneous Melanoma, +2 more conditions

binimetinib, +1 more drug

targeted therapy

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~17 mi. (Cona, Italy, +142 more cities)

Arcispedale S.Anna - Ematologi

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

~23 mi. (Ferrara, Italy, +122 more cities)

A.O.U. di Ferrara

Prostate Adenocarcinoma

radium Ra 223 dichloride

radiation therapy

A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

~30 mi. (Lugo, Italy, +50 more cities)

Ospedale Umberto I ASL di Ravenna Presidio Ospedaliero di Lugo

PD-L1 Expression (CPS >= 1), +5 more biomarkers

Head and Neck Squamous Cell Carcinoma

atezolizumab, +1 more drug

immunotherapy

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

~35 mi. (Ravenna, Italy, +163 more cities)

Investigational Site Number :3800004

CEACAM5 Expression

Non-Squamous Non-Small Cell Lung Carcinoma

tusamitamab ravtansine

chemotherapy, +1 more type

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

~35 mi. (Ravenna, Italy, +141 more cities)

GSK Investigational Site

Multiple Myeloma

belantamab mafodotin

chemotherapy, +1 more type

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~35 mi. (Ravenna, Italy, +144 more cities)

Ospedale Santa Maria Delle Croci

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy